drug · protein
patient view →AT-278
Phase 1updated 2mo agoby Arecor Therapeutics Plc🔗 ChEMBL
Phase 1community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for diabetes mellitus and type 2 diabetes mellitus and 46 investigational indications.
targets
Insulin receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that